We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.39%
2 Technology 15.39%
3 Healthcare 14.54%
4 Industrials 13.38%
5 Energy 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
K
301
DELISTED
Kellanova
K
$2.23M 0.05%
+36,194
New +$2.27M
CATY icon
302
Cathay General Bancorp
CATY
$4.17B
$2.18M 0.05%
85,200
– –
ALXN
303
DELISTED
Alexion Pharmaceuticals
ALXN
$2.14M 0.05%
13,676
-77,000
-85% -$12.2M
TWC
304
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$2.13M 0.05%
14,437
-21,600
-60% -$3.03M
FITB
305
Fifth Third Bancorp
FITB
$49.6B
$2.12M 0.05%
99,200
-401,311
-80% -$8.5M
AIZ icon
306
Assurant
AIZ
$14.1B
$2.11M 0.05%
32,183
– –
BDC icon
307
Belden
BDC
$4.35B
$2.08M 0.05%
+26,600
New +$1.95M
GBL
308
DELISTED
GAMCO Investors, Inc.
GBL
$2.08M 0.05%
46,425
-1,857
-4% -$77.5K
REX icon
309
REX American Resources
REX
$1.41B
$2.05M 0.05%
167,742
+104,388
+165% +$1.15M
SNPS icon
310
Synopsys
SNPS
$70.5B
$2.02M 0.04%
51,900
+3,000
+6% +$114K
TRV icon
311
Travelers Companies
TRV
$78.8B
$2M 0.04%
21,300
– –
AWH
312
DELISTED
Allied World Assurance Co Hld Lt
AWH
$2M 0.04%
+52,500
New +$1.91M
TWTC
313
DELISTED
TW TELECOM INC CL A COM
TWTC
$1.98M 0.04%
49,099
+48,900
+24,573% +$1.61M
MSI icon
314
Motorola Solutions
MSI
$77.6B
$1.97M 0.04%
29,526
– –
AZPN
315
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$1.86M 0.04%
40,079
+3,500
+10% +$162K
FDS icon
316
Factset
FDS
$9.85B
$1.83M 0.04%
15,208
– –
LH icon
317
Labcorp
LH
$26.3B
$1.78M 0.04%
20,219
– –
ARW icon
318
Arrow Electronics
ARW
$10.8B
$1.76M 0.04%
29,177
– –
FN icon
319
Fabrinet
FN
$13.4B
$1.74M 0.04%
84,200
-40,400
-32% -$818K
MON
320
DELISTED
Monsanto Co
MON
$1.71M 0.04%
13,700
+500
+4% +$58.5K
EW icon
321
Edwards Lifesciences
EW
$49.4B
$1.68M 0.04%
117,384
– –
MTX icon
322
Minerals Technologies
MTX
$2.11B
$1.68M 0.04%
25,600
– –
RGA icon
323
Reinsurance Group of America
RGA
$16.2B
$1.68M 0.04%
21,229
– –
WAL icon
324
Western Alliance Bancorporation
WAL
$8.62B
$1.66M 0.04%
69,700
– –
RAD
325
DELISTED
Rite Aid Corporation
RAD
$1.66M 0.04%
11,560
– –
11 12
13
14 15

Similar funds

ICMH
Integrity Capital Management (HK) Central, Hong Kong $19.4M AUM
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.